Pedro Siza Vieira is a Portuguese lawyer and politician. From October 2017 to October 2018 he was Minister Assistant to the Prime-Minister, and he is currently, Assistant Minister to the Prime-Minister and Minister of Economy of the Portuguese Government.
Alexandra Abreu Loureiro is partner at the Brunswick Group, a reputation consulting group which leads in Portugal and in the Portuguese-speaking world.
Diane Villax is Founder Chairman of Hovione, a company she founded in 1959 with her husband, Ivan Villax. Hovione is a worldwide company with a large experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.
Garrett McNamara is a giant wave explorer, renowned for discovering and pioneering when surfing the worlds largest wave in Nazareth. Since then he has shared his experience as a leader.
Daniela Couto is a Principal at Biogeneration Ventures. Daniela is the managing director of Staten Biotech and serves on the board of Catalym. Daniela previously was CEO at Cell2B, a life sciences company that she co-founded dedicated to treat immune and inflammatory diseases.
Rick is Senior Director, New Ventures and Transactions, Oncology at Johnson & Johnson Innovation in London. In this role, Rick leverages his experience and knowledge of the scientific and biotech landscape to identify and evaluate external opportunities and deliver transformative innovation into the pipeline.
Prof. Bruno Silva-Santos is an Associate Professor at the Faculty of Medicine of the University of Lisbon and Principal Investigator at João Lobo Antunes Molecular Institute of Medicine in Lisbon.
Carlos Moedas is a Portuguese civil engineer, economist and politician. Between 2011 and 2014 he was appointed Assistant Secretary of State in the XIX Constitutional Government of Portugal. Since November 1st Moedas is European Commissioner for Research, Science and Innovation.
Executive Director at Fosun International, a leading Chinese conglomerate, where he currently leads the Healthcare Investment team for Europe. He has over 10 years of experience in venture creation, VC and PE experience across US, EU and China. He was on the board of Lymphact, Immunethep and Tonic App.
Peter joined Mercia Asset Management PLC (UK) in 2015 as Head of Life Sciences & Biosciences. He is currently responsible for investing in new companies in the life sciences sector, with over 20 years experience. In addition became Chief Operating Officer in 2018.
Jose Mesa is a Partner at Alta Life Sciences where he invests in drug development and medical devices. Jose was previously Investment Director at Caixa Capital Risc where he lead analysis, negotiation and structuring of investments in life sciences companies.
João Ribas joined Novo Seeds in 2018 as an Investment Associate. Previously, he was an analyst at M Ventures. Among other activities, he started several new ventures in the USA and Europe.
Dirk Kersten is a General Partner at Forbion and focuses primarily on new investments. Dirk was previously a Partner at Gilde Healthcare, where he led their Boston/US operations.
Chief of Business Operations at Nanoform. Gonçalo is a Biochemist by training and has over 20 years experience in the pharmaceutical and venture capital industries.
Jonathan Tobin is an Investment Director at Arix Bioscience where he specializes in biotechnology investments. He currently sits on the board of Artios Pharma, Atox Bio and Mitoconix Bio.
Pablo is the Director of Life Science Investment Funds at Caixa Capital Risc. He currently serves on the Board of Medlumics, Aelix Therapeutics, Minoryx Therapeutics, iProteos, Proteodesign and Sanifit.
Giovanni is a Partner at Medicxi and has been with the firm since its inception in 2016. Prior to Medicxi, Giovanni was a Principal at Index Ventures for four years, having joined in 2012.
Yvonne Redmond is the Speakers Director at Europes biggest science and technology event, the Web Summit. Held each year in Lisbon, Portugal, the Web Summit draws 70.000 people, 2.800 journalists and 18 million Facebook views.
David Braga Malta is a Venture Partner at Vesalius Biocapital. He previously founded NeurIMM, Cell2B and BoostPharma, where he serves(ed) as a manager. He was previously a member of Caixa Capitals venture capital team.
Peter Villax is currently Chairman of Hovione Capital, a VC firm focused on investing in life sciences projects across Europe. Peter is the President of the Portuguese Family Business Association and Board Member of the European Family Businesses Federation.
Ricardo Perdigão Henriques is the CEO of Hovione Capital, a healthcare-specialized VC fund based in Portugal investing in early-stage life sciences projects across Europe.
Lev is Director of Innovation and Sourcing at Versant Ventures where he identifies and evaluates early-stage drug discovery projects, bridging academic and industry knowledge to uncover unexpected therapeutic opportunities.
© All rights reserved Empresas Familiares
Este site usa cookies para melhorar sua experincia de navegação. Ao continuar, aceita a utilização de cookies de acordo com a nossa Poltica de Cookies.